Prior Auth Data Shows What Insurers Won't Disclose

Prior Authorization Metrics Provide New Insights into Insurer Practices

New transparency data on prior authorization approval rates is a step forward—but it's leaving billing teams without the actionable intelligence they need to forecast denials or negotiate fix turnaround times. The metrics available now show which insurers approve faster and which deny more frequently, but the granularity stops there. You still can't reliably predict which CPT codes, provider specialties, or patient demographics will hit resistance at a given plan, which means your prior auth workload remains volatile and your days in AR vulnerable to surprises.

What's Actually Happening

Payers are now reporting approval rates, denial rates, and ~est. average processing times for prior authorization requests—a major shift from the black box environment of the past five years. This data is surfacing real variation: some insurers approve 95%+ of requests within 48 hours; others sit at 70% approval with 5-7 day average turnaround. The visibility is genuine progress.

But critical gaps remain. Most public disclosures don't break down approval rates by medical specialty, procedure type, or diagnosis code. You can't see whether UnitedHealth is denying orthopedic imaging at 30% while approving it at 5% for cardiology. Insurer-specific appeal rates are rarely disclosed, so you can't measure the downstream cost of a denial—how many go to reconsideration versus how many stick. Turnaround times for expedited requests are lumped together with standard processing, obscuring where bottlenecks actually sit.

And the most critical metric—time-to-resolution for appealed denials—remains opaque at most plans.

Why It Matters for Billing Teams

Your prior auth team is already drowning in volume. This new data helps you identify which payers are the worst offenders on turnaround time, but it doesn't help you staff smarter or predict which claims will bounce back. If you knew that Aetna denies 25% of requests for a specific procedure at your location, you could pre-position appeals or build a provider education loop. Instead, you're still reacting claim-by-claim.

The half-transparency also complicates vendor selection. If you're evaluating a prior auth automation platform, you need to know whether it can handle specialty-specific workflows or whether it's generic queue management. The public data doesn't tell you that, so you're left leaning on vendor marketing instead of evidence.

Most pressing: incomplete metrics mask the real cost of prior auth delays. If a claim sits pending for 7 days and then gets denied, that denial compounds your AR aging and pushes collection further out. New data doesn't measure that compounding cost, so CFOs still underestimate the true burden on cash flow.

What To Do About It

• Pull your contract data now. Map approval rates and turnaround times against your fee schedules and volume by plan. Identify the 3-5 worst performers and prioritize those for renegotiation language requiring faster decisions or exemptions for routine procedures.
• Build your own dashboards. Log your internal prior auth denial rates, appeal rates, and time-to-resolution by payer and procedure. Cross-reference that against public insurer metrics—if your data diverges significantly, that's a negotiation point and a flag to investigate.
• Standardize your requests. Payers that see cleaner, more complete prior auth submissions process faster. Create a pre-submission checklist aligned to each plan's specific documentation requirements, not generic templates.
• Audit your appeal strategy. If public data shows a payer's average approval rate is low but your internal data shows yours is higher, reverse-engineer why. You may have found a best practice worth scaling.
• Lobby for granularity. If you're part of a provider network, push your payor contracting team to demand specialty-level and CPT-level approval data in your next negotiation. Opaque metrics protect payers—not you.

The Bigger Picture

Transparency in prior auth is being mandated by regulators and demanded by providers and patients alike, so payers are begrudgingly reporting. But they're reporting at the minimum threshold of compliance, not with the detail that actually changes behavior. Expect regulators to tighten the definition of "transparency" over the next 18-24 months, requiring specialty-level granularity. In the meantime, you can't wait for perfect data—you have to build your own to compete with plans that have it.

The prior auth crisis isn't solved by knowing that Aetna approves 88% of claims in 3 days. It's solved when you know Aetna approves 88% of orthopedic imaging but 62% of rheumatology consults, and you adjust your workflows accordingly.

Published by RevCycleAI Research · August 14, 2026